SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Caroff SN. The neuroleptic malignant syndrome. J. Clin. Psychiatry 1980; 41: 7983.
  • 2
    Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am. J. Psychiatry 1986; 143: 15871598.
  • 3
    Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome; review and analysis of 115 cases. Biol. Psychiatry 1987; 22: 10041020.
  • 4
    Keck PE Jr, Sebastianelli J, Pope HG Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital. J. Clin. Psychiatry 1989; 50: 352355.
  • 5
    Raja M, Altavista MC, Cavallari S, Lubich L. Neuroleptic malignant syndrome and catatonia. A report of three cases. Eur. Arch. Psychiatry Clin. Neurosci. 1994; 243: 299303.
  • 6
    Spivak B, Maline DI, Kozyrev VN et al. Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow. Eur. Psychiatry 2000; 15: 330333.
  • 7
    Deng MZ, Chen GQ, Philips MR. Neuroleptic malignant syndrome in 12 of 9,792 Chinese inpatients exposed to neuroleptics: A prospective. Am. J. Psychiatry 1990; 147: 11491155.
  • 8
    Chopra MP, Prakash SS, Raguram R. The neuroleptic malignant syndrome: An Indian experience. Compr. Psychiatry 1999; 40: 1923.
  • 9
    Montoya A, Ocampo M, Torres-Ruiz A. Neuroleptic malignant syndrome in Mexico. Can. J. Clin. Pharmacol. 2003; 10: 111113.
  • 10
    Önder ME, Şahin AR, Fidaner H, Tan D. Neuroleptic malignant syndrome in a general hospital psychiatry clinic. Turk. Psikiyatri. Derg. 1990; 1: 245248 (in Turkish).
  • 11
    Rivera JM, Garcia-Bragado F, Iriarte LM, Lozno-Gutierrez F, Salgado V, Andreu J. Neuroleptic malignant syndrome an analysis of 9 cases. Med. Clin. (Barc) 1990; 94: 121125.
  • 12
    Hermesh H, Aizenberg D, Weizman A, Lapidot M, Mayor C, Munitz H. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients. Br. J. Psychiatry 1992; 161: 254257.
  • 13
    Keck PE, Pope HG, Cohen BM, McElroy SL, Nierenberg AA. Risk factors for neuroleptic malignant syndrome. A case control study. Arch. Gen. Psychiatry 1989; 46: 914918.
  • 14
    Levenson JL. Neuroleptic malignant syndrome. Am. J. Psychiatry 1985; 142: 11371345.
  • 15
    Rosebush P, Stewart T. A prospective analysis of 24 episodes of NMS. Am. J. Psychiatry 1989; 146: 717725.
  • 16
    Susman VL, Addonizio G. Recurrence of neuroleptic malignant syndrome. J. Nerv. Ment. Dis. 1988; 176: 234241.
  • 17
    Viejo LF, Morales V, Punal P, Perez JL, Sancho RA. Risk factors in neuroleptic malignant syndrome. A case-control study. Acta Psychiatr. Scand. 2003; 107: 4549.
  • 18
    Alpay N, Canbek Ö, Karamustafalıoglu N, Karaakın Y. Neuroleptic malignant syndrome: A case report. Düsünen Adam 1998; 11: 3840 (in Turkish).
  • 19
    Arkonaç O, Verimli A, Soysal H, Atalay H, Türkcan A. Two cases of neuroleptic malignant syndrome. Düsünen Adam 1991; 4: 6163 (in Turkish).
  • 20
    Arpacı B, Ceylan ME, Forta H. Neuroleptic malignant syndrome: A case report. Düsünen Adam 1986; 1: 2022 (in Turkish).
  • 21
    Askın R, Herken H, Derman H. A case with recurrent neuroleptic malignant syndrome. In: Proceedings of the 4th International Symposium on Recent Developments of Clinical Psychopharmacology. TAP, Istanbul, 1998; 377380 (in Turkish).
  • 22
    Aydın N, Ulamıs Y, Banoglu R. Neuroleptic malignant syndrome and ECT: A case report. In: Proceedings of the XXVIII National Congress of Psychiatry. Türkiye Sinir ve Ruh Sağlığı Derneğ, Ankara, 1992; 58 (in Turkish).
  • 23
    Bora E, Saffet Gonul A, Akdeniz F, Vahip S. Neuroleptic malignant-like syndrome induced with low-dose quetiapine treated with electroconvulsive therapy. Eur. Psychiatry 2003; 18: 323.
  • 24
    Erisik K, Bayülkem K. Neuroleptic malignant syndrome. Haseki Tıp Bülteni 1992; 12: 131133.
  • 25
    Eryüce Ö, Tanverdi A, Şengül A. A case with neuroleptic malignant syndrome. Dirim 1994; 69: 229231 (in Turkish).
  • 26
    Gedizoglu M, Basoglu M, Budak F. Neuroleptic malignant syndrome. Nörolojik Bilimler Dergisi 1987; 2: 4042 (in Turkish).
  • 27
    Güney M, Akbostancı C. Neuroleptic malign syndrome. Poster presented at XXVI. Congress of National Psychiatry and Neurology, Proceedings book. 1990; 129130 (in Turkish).
  • 28
    Herken H, Kaya N, Askın R, Kucur R. Neuroleptic malignant syndrome: 5 cases. Klinik Psikiyatri 1998; 2: 120124 (in Turkish).
  • 29
    Isık N, Karaagaç MN. A case of neuroleptic malignant syndrome. Klinik Gelisim 1990; 3: 911913 (in Turkish).
  • 30
    Orhan O, Zencirci B, Öksüz H, Bayır A, Karaaslan F. Neuroleptic malignant syndrome: A case with tardive onset by polypharmacy. In: Proceedings of the 40th National Congress of Psychiatry. TPD, Izmir, 2004; 545547 (in Turkish).
  • 31
    Ökten F, Tulunay M, Yavuzer Ş. Neuroleptic malign syndrome. Ankara Tıp Mecmuası 1998; 43: 267268 (in Turkish).
  • 32
    Önder ME, Cihan R, Şenol S. Could catatonia be the predictor of neuroleptic malignant syndrome: A case report. Turk Psikiyatri Derg 1994; 5: 226230 (in Turkish).
  • 33
    Önder ME, Şahin AR, Fidaner H, Tan D. ECT in the treatment of NMS. Turk Psikiyatri Derg 1990; 1: 203204 (in Turkish).
  • 34
    Sır A, Ozkan M, Özdemir E, Özkan Ü, Bebek B. Neuroleptic malignant syndrome developed on normal pressure hydrocephalus. Klin. Psikofarmakol. Bülteni 1998; 8: 4346 (in Turkish).
  • 35
    Sürmeli A, Battal S, Aydın H. Neuroleptic malignant syndrome. In: Proceedings of the XXIV National Congress of Psychiatry and Neurology. GATA, Ankara, 1988; 935941 (in Turkish).
  • 36
    Şenol S, Yüksel N, Şener. Neuroleptic malignant syndrome: A case report. In: Proceedings of the XXIV National Congress of Psychiatry and Neurology. GATA, Ankara, 1988; 929934 (in Turkish).
  • 37
    Turhan G, Çetinkaya M, Erol İ. Neuroleptic malignant syndrome: Two cases. Göztepe Hastanesi Tıp Bülteni 1989; 4: 258263 (in Turkish).
  • 38
    Ünal F, Hizli S, Ozyurek H, Sonuvar B. Fever and altered consciousness are not always equal to central nervous system infection: Neuroleptic malignant syndrome in a 15-year-old girl. Turk. J. Pediatr. 1996; 38: 505510 (in Turkish).
  • 39
    Ünal F, Tunca Z. Does biperidene lactate have a role in the treatment of neuroleptic malignant syndrome? In: Proceedings of the XXVII National Congress of Psychiatry. TPD, Antalya, 1991; 217 (in Turkish).
  • 40
    Yaluğ İ, Tural Ü, Kırmızı Alsan E, Önder E. Neuroleptic malignant syndrome: A case report and review of literature. 3P Dergisi 2005; 13: 115118 (in Turkish).
  • 41
    Yildiz A, Alkin T, Ozerdem A, Sagduyu K, Demopulos CM. Neuroleptic malignant syndrome: A case that may shed new light into the etiology and treatment. Aust. N. Z. J. Psychiatry 2003; 37: 493494.
  • 42
    Yumru M, Savas HA, Savas E. Single dose chlorpromazine induced neuroleptic malignant syndrome responded to ECT: A case report. Türkiyede Psikiyatri 2005; 7: 126128 (in Turkish).
  • 43
    Zoroglu S, ÜÇok A, Köknel Ö. Neuroleptic malignant syndrome associated with thyrotoxic crisis: A case report. Nöropsikiyatri Arsivi 1994; 31: 151154 (in Turkish).
  • 44
    Pearlman CA. Neuroleptic malignant syndrome: A review of literature. J. Clin. Psychopharmacol. 1986; 6: 257270.
  • 45
    Sayın A, Karslıoglu E, Yavas G, Candansayar S. The use of antipyschotic prescription for an university psychiatry clinic: A retrospective study. Klin. Psikofarmakol. Bülteni 2006; 16: 160166 (in Turkish).
  • 46
    Henderson VM, Wooten GF. Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade? Neurology 1981; 31: 132137.
  • 47
    Coons DJ, Hillmann FJ. Treatment of neuroleptic malignant syndrome with dantrolene sodium. Am. J. Psychiatry 1982; 139: 344345.
  • 48
    Horn E, Lach B, Lapierre Y, Hrdina P. Hypothalamic pathology in the neuroleptic malignant syndrome. Am. J. Psychiatry 1988; 145: 617620.
  • 49
    Balzan M, Cacciottolo JM. Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma. Br. J. Psychiatry 1992; 161: 257258.
  • 50
    Lee JW. Serum iron in catatonia and neuroleptic malignant syndrome. Biol. Psychiatry 1998; 44: 499507.
  • 51
    Straker M. Neuroleptic malignant syndrome: Fatalities associated with neuroleptic use and schizophrenia. Psychiatry J. Univ. Ottowa 1985; 142: 11371145.
  • 52
    Allshop P, Turigley AJ. The neuroleptic malignant syndrome. Anesthesia 1987; 42: 4953.
  • 53
    Zubenko G, Pope HG. Management of a case of neuroleptic malignant syndrome with bromocriptine. Am. J. Psychiatry 1983; 140: 16191620.
  • 54
    Kontaxakis VP, Christodoulou GN, Markidis MP, Havaki-Kontaxaki BJ. Treatment of a mild form of a neuroleptic malignant syndrome. Acta Psychiatr. Scand. 1988; 78: 396398.
  • 55
    Hermesh H, Aisenberg D, Weizman A. A successful electroconvulsive treatment of neuroleptic malignant syndrome. Acta Psychiatr. Scand. 1987; 75: 237239.
  • 56
    Caroff SN, Mann SC, Keck PE. Specific treatment of the neuroleptic malignant syndrome. Biol. Psychiatry 1998; 44: 378381.
  • 57
    Woodbury MM, Woodbury MA. Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome. J. Am. Acad. Child Adolesc. Psychiatry 1992; 31: 11611164.
  • 58
    Francis A, Koch M, Chandragiri S, Rizvi S, Petrides G. Is lorazepam a treatment for neuroleptic malignant syndrome? CNS Spectr. 2000; 5: 5457.